-
Risk in the AirAir pollution can increase a person's risk of developing cancer, a burden that isn't shared equally in every neighborhood.
by Jon Kelvey
-
Practical Considerations for CannabisPeople with cancer who are thinking about using cannabis to manage cancer-related symptoms should seek answers to some practical questions.
by Kate Yandell
-
An Emerging Treatment for Metastatic Prostate CancerA drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer.
by Pamela Rafalow Grossman
-
Exercise, Cancer and AgingA study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline.
by Marcus A. Banks
-
Preconceived Notions: Cancer, Fertility Coverage and the LawInsurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state.
by Shelly Rosenfeld
-
Drug Delays Recurrence in People With Early-Stage Breast CancerPeople who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
-
Open Medical Records: Pros and ConsPatients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
-
Remote CareAfter adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.
by Jon Kelvey
-
Moving Away From the Maximum Tolerated DoseThe FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
-
The Individual Sphere of InfluenceCan discussion of health inequities lead to actionable change?
by Marci A. Landsmann
Challenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
